Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […]